4,439 results match your criteria: "Centre Hospitalier Lyon-sud[Affiliation]"

Currently, the guidelines for audiological and vestibular follow-up in children with congenital cytomegalovirus (CMV) are not well-defined. The general recommendation is to evaluate hearing in all children with congenital CMV at the same intervals: once every 3-6 months up to 1 year of age, once every 6 months from 1 to 3 years of age, and once a year from 3 to 6 years of age. Additionally, there are no universally accepted protocols for the vestibular follow-up of children with congenital CMV, although video head impulse test (v-HIT) and cervical vestibular-evoked myogenic potentials (cVEMPs) are sometimes used.

View Article and Find Full Text PDF

Context: Gastric and oesophageal cancers are common. They are also expected to increase in incidence in the next few years and are characterized by poor prognosis. Surprisingly, whereas the incidence of severe anxiety and depression is high in patients with gastric and oesophageal cancers, the influence of symptoms of depression and anxiety on postoperative complications has barely been explored.

View Article and Find Full Text PDF

Treatment of type 2 diabetes with MASLD: new evidence for personalised medicine.

Gut

October 2024

Centre Hospitalier Lyon Sud, Endocrinologie Diabète et Nutrition, Hospices Civils de Lyon, Pierre-Bénite, Auvergne-Rhône-Alpes, France

View Article and Find Full Text PDF

During a fatal disease, patients often request updated information on their prognosis. After patients have already survived a certain time, conditional survival captures their future survival probability. We investigated conditional overall and failure-free survival in 473 younger mantle cell lymphoma (MCL) patients from a randomized phase III trial comparing immunochemotherapies R-CHOP and alternating R-CHOP/R-DHAP before autologous transplantation.

View Article and Find Full Text PDF

Despite the growing evidence supporting the existence of CNS involvement in acute and chronic graft-versus-host disease (CNS-GvHD), the characteristics and course of the disease are still largely unknown. In this multicenter retrospective study, we analyzed the clinical, biological, radiological, and histopathological characteristics, as well as the clinical course of 66 patients diagnosed with possible CNS-GvHD (pCNS-GvHD), selected by predetermined diagnostic criteria. Results were then contrasted depending on whether pCNS-GvHD occurred before or after day 100 following allogeneic hematopoietic stem cell transplantation.

View Article and Find Full Text PDF

Endogenous retroelements (EREs), which comprise half of the human genome, play a pivotal role in genome dynamics. Some EREs retained the ability to encode proteins, although most degenerated or served as a source for novel genes and regulatory elements during evolution. Despite ERE repression mechanisms developed to maintain genome stability, widespread pervasive ERE activation is observed in cancer including hematological malignancies.

View Article and Find Full Text PDF
Article Synopsis
  • IgG4 auto-antibodies targeting Caspr2 are linked to various neurological symptoms, but the exact mechanisms of how they cause neuronal dysfunction are not fully understood.
  • The study identifies two distinct biosignatures related to clinical phenotypes: limbic encephalitis (LE) and peripheral nerve hyperexcitability, with specific immune features associated with each condition.
  • Findings suggest that the presence of IgG1 antibodies and their pro-inflammatory effects are crucial for the development of LE, indicating that therapies targeting these pathways could improve patient outcomes.
View Article and Find Full Text PDF

Background: Bone metastasis is a significant concern in advanced solid tumors, contributing to diminished patient survival and quality of life due to skeletal-related events (SREs). Denosumab (DMAB), a monoclonal antibody targeting the receptor activator of nuclear factor kappa-B ligand (RANKL), is used to prevent SREs in such cases. The RANK/RANKL axis, crucial in immunological processes, has garnered attention, especially with the expanding use of immune checkpoint inhibitors (ICI) in modern oncology.

View Article and Find Full Text PDF

Therapy-related acute myeloid leukemia with inv(16)(p13.1q22).

Int J Hematol

December 2024

Laboratoire d'hématologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.

View Article and Find Full Text PDF
Article Synopsis
  • Diagnosing acral melanocytic lesions, like acral nevi and melanoma, can be difficult, and the BRAAFF checklist was developed to assist in this process but hasn't been validated yet.
  • In a study, varying experts diagnosed images of nevi and melanomas using the BRAAFF checklist online, yielding a sensitivity of 92.5% and a specificity of 65.0%, comparable to traditional pattern recognition.
  • The checklist showed varying levels of agreement among raters based on experience, and a simplified version achieved similar sensitivity with slightly lower specificity, suggesting that the BRAAFF checklist is a helpful but not superior diagnostic tool.
View Article and Find Full Text PDF
Article Synopsis
  • * The study, called KOMET-001, was conducted in multiple countries and involved dose-escalation and validation phases, with patients in specific molecular subtypes receiving varying doses of ziftomenib over 28-day cycles.
  • * Results indicated that 83 patients were treated with ziftomenib from September 2019 to August 2022, and the findings are crucial for determining the drug's safety and effectiveness for future phases of clinical testing.
View Article and Find Full Text PDF

Background: While SARS-CoV2 infection has been shown to be a significant risk-factor for several secondary bacterial, viral and Aspergillus infections, its impact on intensive care unit (ICU)-acquired candidemia (ICAC) remains poorly explored.

Method: Using the REA-REZO network (French surveillance network of ICU-acquired infections), we included all adult patients hospitalized for a medical reason of admission in participating ICUs for at least 48 h from January 2020 to January 2023. To account for confounders, a non-parsimonious propensity score matching was performed.

View Article and Find Full Text PDF

Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial.

Leukemia

December 2024

Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, Department of Hematology, University Medical Center, Rotterdam, The Netherlands.

Article Synopsis
  • Epcoritamab, a bispecific antibody targeting CD3 and CD20, showed promising long-term results as a monotherapy for relapsed or refractory large B-cell lymphoma (LBCL) in the EPCORE NHL-1 study, with a 63.1% overall response rate and a 40.1% complete response rate after a median follow-up of 25.1 months.
  • The estimated 24-month progression-free survival (PFS) and overall survival (OS) rates were 27.8% and 44.6%, respectively, with 64.2% of complete responders maintaining their response at that time.
  • Most treatment-emergent adverse events were manageable, with cytokine release syndrome
View Article and Find Full Text PDF
Article Synopsis
  • The PRECINCT study evaluated how different morphological appearances of peritoneal malignancies on imaging related to pathological findings in a large patient group.
  • It involved the analysis of imaging from 630 patients across seven centers, using 24 morphological terms to describe peritoneal tumors, highlighting high pathological positivity rates for several specific appearances.
  • The study recommends standardizing morphological descriptions in radiology reports to improve diagnostic accuracy and proposes that expert radiologists develop a consensus on terminology for better communication in clinical practice.
View Article and Find Full Text PDF

Central venous catheter-related infection: does insertion site still matter? A French multicentric cohort study.

Intensive Care Med

November 2024

REA-REZO Infections et Antibiorésistance en Réanimation, Hôpital Henry Gabrielle, Saint-Genis-Laval, France.

Purpose: We aim to evaluate the association between central venous catheter (CVC) insertion site and microbiological CVC complications in a nationwide cohort.

Methods: This study was conducted using the healthcare-associated infection surveillance cohort "REA-REZO" involving 193 intensive care units (ICUs). All CVC inserted and removed during the same ICU stay between January 1st 2018 and December 31st 2022 were eligible but only those whose tips were sent for microbiological analysis were included.

View Article and Find Full Text PDF
Article Synopsis
  • Advanced systemic mastocytosis (AdvSM) is a complex condition linked to poor outcomes, and while midostaurin is the first approved treatment, its long-lasting effectiveness is limited.
  • Various prognostic scoring systems like MARS, IPSM, and GPSM have been developed to assess patients' outcomes, but it's essential to tailor these scores to specific AdvSM subtypes for better accuracy.
  • A study of patients treated with midostaurin revealed that MARS and AdvSM subtype significantly predict overall survival, identifying five distinct patient subgroups with varying median survival times, highlighting the need for personalized management strategies.
View Article and Find Full Text PDF

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Ann Oncol

November 2024

Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain; Medical Oncology Department, Translational Oncology Group, CIMA, Universidad de Navarra, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.

Background: The phase III PRIMA/ENGOT-OV26/GOG-3012 trial met its primary endpoint. Niraparib first-line maintenance significantly prolonged progression-free survival (PFS) among patients with newly diagnosed advanced ovarian cancer that responded to first-line platinum-based chemotherapy, regardless of homologous recombination deficiency (HRD) status. Final overall survival (OS) results are reported.

View Article and Find Full Text PDF

Internal Nasal Valve Collapse Treatment by Endonasal Hyaluronic Acid Injection.

Aesthetic Plast Surg

September 2024

Service de Chirurgie Plastique, Esthétique et Réparatrice, Hospices Civils de Lyon, Hôpital Croix Rousse, F-69003, Lyon, France.

Article Synopsis
  • This study was designed to evaluate the effectiveness of hyaluronic acid injections for treating internal nasal valve collapse (IVC) in patients who experienced nasal obstruction after rhinoplasty.
  • It involved a group of 22 adult patients who underwent rhinomanometry and completed symptom questionnaires before and after receiving the injections, with significant improvements noted one month after treatment.
  • Results showed that 91% of patients were below the diagnostic threshold for IVC one month post-injection, and both subjective and objective measures of nasal obstruction significantly improved, suggesting hyaluronic acid could be a viable non-surgical treatment option for IVC.
View Article and Find Full Text PDF

Background And Aim: In this report from Phase 1 of the prospective, observational, PRECINCT (Pattern of peritoneal dissemination and REsponse to systemic Chemotherapy IN Common and uncommon peritoneal Tumours) study, a correlation was performed between the radiological PCI (peritoneal cancer index; rPCI) and surgical PCI (sPCI). The impact of timing of peritoneal malignancy (PM) and previous abdominal surgery was also studied.

Methods: The rPCI and sPCI were considered the 'same' if they differed by ≤ 3 points.

View Article and Find Full Text PDF

Mortality, perioperative complications and surgical timelines in hip fracture patients: Comparison of the Spanish with the non-Spanish Cohort of the HIP ATTACK-1 trial.

Injury

November 2024

Population Health Research Institute, Hamilton, Ontario, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Background: Hip fractures carry a substantial risk of complications and death. This study aimed to report the 90-day incidence of mortality, major perioperative complications and in-hospital timelines after a hip fracture in the Spanish HIP ATTACK-1 trial cohort, comparing with the non-Spanish cohort.

Methods: Prospective cohort study of Spanish patients nested in the HIP ATTACK-1 trial.

View Article and Find Full Text PDF

Sustained elevation of calprotectin associates with delayed appearance of myeloid-derived suppressor cells in patients with septic shock.

J Crit Care

December 2024

Hospices Civils de Lyon, Immunology Laboratory, Hôpital E. Herriot, Lyon, France; Université de Lyon, EA 7426 "Pathophysiology of Injury-Induced Immunosuppression", Université Claude Bernard Lyon_1, Lyon, France. Electronic address:

View Article and Find Full Text PDF